Xiaojun Feng
Impact in
- Geriatrics and Gerontology top 2%
- Sirtuins and Resveratrol in Medicine
- Pharmacology top 2%
- Berberine and alkaloids research
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
Papers in
-
- Signaling Pathways in Disease 5
- Metabolism, Diabetes, and Cancer 4
- Peroxisome Proliferator-Activated Receptors 3
-
- Microbial Natural Products and Biosynthesis 4
- Co-authors
- Suowen Xu (12 shared papers)Shou‐Mei Wang (12 shared papers)Lei Zhang (1 shared paper)Lingli Li (4 shared papers)Peter J. Little (4 shared papers)Wenxu Chen (3 shared papers)Yanan Wang (2 shared papers)Liqin Tang (4 shared papers)
- Journals
- Archives of Biochemistry and Biophysics (4 papers)Frontiers in Pharmacology (3 papers)Cancer Biology & Therapy (2 papers)The International Journal of Biological Markers (2 papers)Plant Disease (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiaojun Feng
55 papers receiving 2.4k citations
Xiaojun Feng's Hit Papers
Peers
Comparison fields: 5 of 122
- Geriatrics and Gerontology 96
- Pharmacology 411
- Cancer Research 324
- Biochemistry 108
- Molecular Biology 956
Countries citing papers authored by Xiaojun Feng
This map shows the geographic impact of Xiaojun Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojun Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojun Feng more than expected).
Fields of papers citing papers by Xiaojun Feng
This network shows the impact of papers produced by Xiaojun Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojun Feng. The network helps show where Xiaojun Feng may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaojun Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics Hit paper breakdown → | 2019 | 342 |
| 2 | 2019 | 183 | |
| 3 | 2011 | 175 | |
| 4 | 2020 | 116 | |
| 5 | 2018 | 114 | |
| 6 | 2011 | 110 | |
| 7 | 2021 | 97 | |
| 8 | 2012 | 88 | |
| 9 | 2018 | 83 | |
| 10 | 2021 | 75 | |
| 11 | 2020 | 65 | |
| 12 | 2020 | 46 | |
| 13 | 2018 | 45 | |
| 14 | 2014 | 42 | |
| 15 | 2012 | 42 | |
| 16 | 2016 | 40 | |
| 17 | 2021 | 39 | |
| 18 | 2015 | 38 | |
| 19 | 2013 | 36 | |
| 20 | 2010 | 36 |
About Xiaojun Feng
Xiaojun Feng is a scholar working on Molecular Biology, Pharmacology, Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 57 papers that have together received 2.4k indexed citations. Recurring topics across this work include Signaling Pathways in Disease (5 papers), Metabolism, Diabetes, and Cancer (4 papers), Cancer Mechanisms and Therapy (4 papers), Peptidase Inhibition and Analysis (4 papers), Diabetes Treatment and Management (4 papers), MicroRNA in disease regulation (4 papers), Microbial Natural Products and Biosynthesis (4 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). The work is most often cited by research in Geriatrics and Gerontology (96 citations), Pharmacology (411 citations), Cancer Research (324 citations), Biochemistry (108 citations) and Molecular Biology (956 citations). Xiaojun Feng has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Suowen Xu, Shou‐Mei Wang, Lei Zhang, Lingli Li, Peter J. Little, Wenxu Chen, Yanan Wang, Liqin Tang, Peiqing Liu and Jianping Weng. Their work appears in journals such as Archives of Biochemistry and Biophysics, Frontiers in Pharmacology, Cancer Biology & Therapy, The International Journal of Biological Markers and Plant Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.